Back
Design Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
DSGN
Design Therapeutics, Inc.
Last Price:
$9.71
Seasonality Move:
-15.75%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Design Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.3 | Buy |
| 20-day SMA: | 9.3 | Buy |
| 50-day SMA: | 7.75 | Buy |
| 200-day SMA: | 5.33 | Buy |
| 8-day EMA: | 9.32 | Buy |
| 20-day EMA: | 9.03 | Buy |
| 50-day EMA: | 8.08 | Buy |
| 200-day EMA: | 6.08 | Buy |
Design Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 60.13 | Buy |
| Chaikin Money Flow: | 696291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.14 - 9.74) | Buy |
| Bollinger Bands (100): | (5.15 - 8.27) | Buy |
Design Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics, Inc. Stock
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.68 while DSGN 8-day simple moving average is 9.30, which is a Buy signal.
-
The stock price of DSGN is 9.68 while Design Therapeutics, Inc. 20-day SMA is 9.30, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day simple moving average is 7.75 while DSGN share price is 9.68, making it a Buy technically.
-
DSGN stock price is 9.68 and Design Therapeutics, Inc. 200-day simple moving average is 5.33, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Buy
67
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. a Buy or a Sell?
-
Design Therapeutics, Inc. stock is rated a BuyThe current Design Therapeutics, Inc. [DSGN] share price is $9.68. The Score for DSGN is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Design Therapeutics, Inc. Stock Info
Market Cap:
551.4M
Price in USD:
9.68
Share Volume:
886.5K
Design Therapeutics, Inc. 52-Week Range
52-Week High:
10.31
52-Week Low:
2.60
Buy
67
Design Therapeutics, Inc. (DSGN)
is a Buy
Design Therapeutics, Inc. Share Price Forecast
-
What is the Design Therapeutics, Inc. stock price today?The Design Therapeutics, Inc. stock price is 9.68 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics, Inc. is not overvalued.
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.68 while DSGN 8-day exponential moving average is 9.32, which is a Buy signal.
-
The stock price of DSGN is 9.68 while Design Therapeutics, Inc. 20-day EMA is 9.03, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day exponential moving average is 8.08 while DSGN share price is 9.68, making it a Buy technically.
-
DSGN stock price is 9.68 and Design Therapeutics, Inc. 200-day simple moving average is 6.08, creating a Buy signal.
Fundamental Analysis of Design Therapeutics, Inc.
Is Design Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Design Therapeutics, Inc.
Should I short Design Therapeutics, Inc. stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.44, suggesting Design Therapeutics, Inc. is a Buy
-
Design Therapeutics, Inc. Relative Strength Index (RSI) is 60.13, which suggest Design Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Design Therapeutics, Inc. is (8.14 - 9.74), which suggest Design Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Design Therapeutics, Inc. is (5.15 - 8.27), which suggest Design Therapeutics, Inc. is a Buy
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.